Bausch Health Companies Inc. Cash Flow Statement
BHC / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Bausch Health Companies Inc. generated $1.4B in operating cash flow and $1.0B in free cash flow in FY2025. Free cash flow margin was 9.8% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $157.0M | -$46.0M | -$948.0M | -$560.0M | -$948.0M | -$4.1B | $2.4B | -$2.4B | $2.4B | -$2.4B | -$288.0M | $880.0M | -$863.6M | -$116.0M | $159.6M |
| Depreciation & Amortization | $1.2B | $1.3B | $1.6B | $1.8B | $1.6B | $2.8B | $2.9B | $2.9B | $2.9B | $2.9B | $2.5B | $1.6B | $2.0B | $986.2M | $612.6M |
| Operating Cash Flow | $1.4B | $1.6B | $1.4B | $1.1B | $1.4B | $1.5B | $2.3B | $2.1B | $2.3B | $2.1B | $2.3B | $2.3B | $1.0B | $656.6M | $640.5M |
| Capital Expenditures | $397.0M | $337.0M | $269.0M | $302.0M | $269.0M | $157.0M | $171.0M | $235.0M | $171.0M | $235.0M | $235.0M | $292.0M | $115.3M | $107.6M | $58.5M |
| Free Cash Flow | $1.0B | $1.3B | $1.2B | $809.0M | $1.2B | $1.3B | $2.1B | $1.9B | $2.1B | $1.9B | $2.0B | $2.0B | $926.7M | $549.0M | $582.0M |
| Share Buybacks | - | - | - | - | - | - | - | - | $0 | $0 | $72.0M | $0 | $55.6M | $280.7M | $639.2M |
| FCF Margin | 9.8% | 13.1% | 13.7% | 10.1% | 13.7% | 16.0% | 24.3% | 19.1% | 100.5% | 78.1% | 19.4% | 24.6% | 16.1% | 15.8% | 24.0% |